Nanocarriers in Prostate Cancer
Academic Press Inc (Verlag)
978-0-443-33208-1 (ISBN)
This book bridges the gap between cutting-edge research and clinical applications, offering insights into how various nanocarriers enhance drug delivery, improve imaging techniques, and provide targeted, less invasive treatments. It serves as a valuable resource for developing more effective, personalized treatments, leading to improved patient outcomes and reduced toxicity associated with traditional therapies.
Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences. Dr. Devesh U. Kapoor is currently serving as a Professor at Dr. Dayaram Patel Pharmacy College, Bardoli, District Surat, Gujarat. The institution is funded by the Directorate of Technical Education (DTE), Government of Gujarat, and is affiliated with Gujarat Technological University. Dr. Kapoor is alumnus of University of Rajasthan, Jaipur and Department of Pharmaceutics, BN College of Pharmacy, Rajasthan University of Health Sciences, Jaipur, Rajasthan, India. He was awarded a Ph.D. in Pharmaceutical Sciences in 2013. Dr. Kapoor serves as an Associate Editor for Naunyn-Schmiedebergs Archives of Pharmacology (Springer Nature), Future Journal of Pharmaceutical sciences (Springer Open), Scientific Reports (Springer Nature), Recent Advances in Drug Delivery & Formulation (Bentham Science) and PLOS One, Frontiers in Medicine - Precision Medicine and Frontiers in surgery. He is a Consulting Editor for Cytotechnology (Springer). He has peer-reviewed manuscripts for approximately 135 prestigious journals from publishers such as Elsevier, MDPI, Springer, Wiley, Frontiers, Dove Press, Bentham Science, Taylor & Francis, Wolters Kluwer (Medknow), and De Gruyter. With over 20 years of experience in teaching and academic administration, Dr. Kapoor has published more than 175 research and review articles in reputed national and international journals. In addition to his editorial responsibilities, Dr. Kapoor is currently editing 18 international books with publishers such as Elsevier, Springer, Wiley, Taylor & Francis, CRC Press, RSC. He has also contributed 50 book chapters published by renowned publishers including Elsevier, Bentham Science, MDPI, Springer, RSC and Wiley. He is currently supervising four Ph.D. students, focusing on nanodrug delivery systems and modified drug release from Gujarat Technological University, Ahemdabad. He fetched research and event organization grants from various government bodies including the Gujarat Council of Science & Technology (GUJCOST), Gujarat State Biotechnology Mission (GSBTM), and AICTE-ATAL for national seminars and faculty development programs. Dr. Kapoor holds 8 design patents and has delivered over 20 expert talks. He is frequently invited to speak at scientific sessions in national conferences, seminars, and workshops. Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals. Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.
1. Introduction
2. Polymeric Nanoparticles: Advancing Prostate Cancer Treatment
3. Advances in silica-based nanoparticles for targeting prostate cancer
4. Breakthrough in magnetic nanoparticles for management of prostate cancer
5. Innovative approaches of metallic (gold, silver) nanoparticles in targeting of prostate cancer
6. Recent application of liposomes, niosomes and exosomes in precise targeting of prostate cancer
7. Therapeutic Potential of Dendrimers in Prostate Cancer: Advances and Challenges
8. Carbon Nanotubes in Prostate Cancer: Emerging Frontiers in Diagnosis and Therapy
9. Targeted therapy of quantum dots against prostate cancer
10. Nanoemulsions and Nanosuspensions: Innovative Nanocarrier Systems for Prostate Cancer Management
11. Nanogels in Prostate Cancer: A Novel Avenue for Targeted Therapy and Enhanced Drug Delivery
12. DNA Origami Nanocarriers: Revolutionizing Prostate Cancer Therapy
| Erscheinungsdatum | 02.12.2025 |
|---|---|
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 191 x 235 mm |
| Gewicht | 450 g |
| Themenwelt | Naturwissenschaften ► Biologie |
| ISBN-10 | 0-443-33208-8 / 0443332088 |
| ISBN-13 | 978-0-443-33208-1 / 9780443332081 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
